TY - JOUR AU - do Vale, Daniela Neves Fernandes AU - Eduardo Maggi, Luís AU - Pereira, Wagner Coelho de Albuquerque PY - 2021/08/15 Y2 - 2024/03/29 TI - THE FOLLOW-UP OF DIABETIC PATIENTS UNDER A PRIMARY CARE PROGRAM IN THE CITY OF RIO BRANCO – ACRE - BRAZIL JF - Multidisciplinary Sciences Reports JA - MS VL - 1 IS - 1 SE - IV - CIÊNCIAS DA SAÚDE DO - 10.54038/ms.v1i1.6 UR - https://multidisciplinarysciences.org/multidisciplinaysciences/article/view/6 SP - 1 - 14 AB - <p><strong>Aims:</strong> Analyze the monitoring of patients with Diabetes Mellitus treated in the Family Health Strategy in the city Rio Branco, Acre State, Brazil. <strong>Methods:</strong> The study is an observational, analytical, cross-sectional research with a quantitative approach. Held from January 2015 to December 2016, in 12 health units (Family Health Strategy - ESF), in the city of Rio Branco, Acre. For data collection, a simple random drawing of a Family Health Group from each Health segment was carried out. After the drawing, a Verification Form was applied, developed from the recommendations of the Ministry of Health for monitoring diabetic patients. <strong>Results:</strong> In the 306 records analyzed, there was a predominance of females (68%), with an average age of 61.6 (SD ± 13) years. As for the metabolic control variables, the most prevalent test was fasting blood glucose (85%), with an average of 211.6 mg / dl. Regarding the number of medical consultations per year, in 2015, 216 consultations were carried out, with 36.9% of patients having three or more consultations / year, this number rose to 253 in 2016, with more than 3 consultations/year (48.1%). Metformin was the most used medication (77.8%), followed by Glibenclamide (53.3%) and insulin (22%). <strong>Conclusions:</strong> &nbsp;FHS groups in the city of Rio Branco, Acre partially follow the guidelines of the Ministry of Health in monitoring diabetic patients. The motives for that are yet to be evaluates, nevertheless it can have an unfavorable impact on their quality of life.</p> ER -